Genetic basis of potential therapeutic strategies for craniosynostosis - PubMed (original) (raw)
Review
. 2010 Dec;152A(12):3007-15.
doi: 10.1002/ajmg.a.33703.
Affiliations
- PMID: 21082653
- DOI: 10.1002/ajmg.a.33703
Review
Genetic basis of potential therapeutic strategies for craniosynostosis
Heather Melville et al. Am J Med Genet A. 2010 Dec.
Abstract
Craniosynostosis, the premature fusion of one or more cranial sutures, is a common malformation of the skull that can result in facial deformity and increased intracranial pressure. Syndromic craniosynostosis is present in ∼15% of craniosynostosis patients and often is clinically diagnosed by neurocranial phenotype as well as various other skeletal abnormalities. The most common genetic mutations identified in syndromic craniosynostosis involve the fibroblast growth factor receptor (FGFR) family with other mutations occurring in genes for transcription factors TWIST, MSX2, and GLI3, and other proteins EFNB1, RAB23, RECQL4, and POR, presumed to be involved either upstream or downstream of the FGFR signaling pathway. Both syndromic and nonsyndromic craniosynostosis patients require early diagnosis and intervention. The premature suture fusion can impose pressure on the growing brain and cause continued abnormal postnatal craniofacial development. Currently, treatment options for craniosynostosis are almost exclusively surgical. Serious complications can occur in infants requiring either open or endoscopic repair and therefore the development of nonsurgical techniques is highly desirable although arguably difficult to design and implement. Genetic studies of aberrant signaling caused by mutations underlying craniosynostosis in in vitro calvarial culture and in vivo animal model systems have provided promising targets in designing genetic and pharmacologic strategies for systemic or adjuvant nonsurgical treatment. Here we will review the current literature and provide insights to future possibilities and limitations of therapeutic applications.
© 2010 Wiley-Liss, Inc.
Similar articles
- Genetics of craniosynostosis: review of the literature.
Ciurea AV, Toader C. Ciurea AV, et al. J Med Life. 2009 Jan-Mar;2(1):5-17. J Med Life. 2009. PMID: 20108486 Free PMC article. Review. - Craniosynostosis syndromes in the genomic era.
Aleck K. Aleck K. Semin Pediatr Neurol. 2004 Dec;11(4):256-61. doi: 10.1016/j.spen.2004.10.005. Semin Pediatr Neurol. 2004. PMID: 15828709 Review. - Molecular and cellular bases of syndromic craniosynostoses.
Bonaventure J, El Ghouzzi V. Bonaventure J, et al. Expert Rev Mol Med. 2003 Jan 29;5(4):1-17. doi: 10.1017/S1462399403005751. Expert Rev Mol Med. 2003. PMID: 14987407 Review. - Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
Ignelzi MA Jr, Wang W, Young AT. Ignelzi MA Jr, et al. J Bone Miner Res. 2003 Apr;18(4):751-9. doi: 10.1359/jbmr.2003.18.4.751. J Bone Miner Res. 2003. PMID: 12674336 - Somatic FGFR and TWIST mutations are not a common cause of isolated nonsyndromic single suture craniosynostosis.
Anderson PJ, Cox TC, Roscioli T, Elakis G, Smithers L, David DJ, Powell B. Anderson PJ, et al. J Craniofac Surg. 2007 Mar;18(2):312-4. doi: 10.1097/scs.0b013e31802d6e76. J Craniofac Surg. 2007. PMID: 17414280
Cited by
- The spontaneous mouse mutant low set ears (Lse) is caused by tandem duplication of Fgf3 and Fgf4.
Luzzio A, Edie S, Palmer K, Caddle LB, Urban R, Goodwin LO, Welsh IC, Reinholdt LG, Bergstrom DE, Cox TC, Donahue LR, Murray SA. Luzzio A, et al. Mamm Genome. 2023 Sep;34(3):453-463. doi: 10.1007/s00335-023-09999-8. Epub 2023 Jun 21. Mamm Genome. 2023. PMID: 37341808 - Molecular Mechanisms Involved in Craniosynostosis.
Yapijakis C, Pachis N, Sotiriadou T, Vaila C, Michopoulou V, Vassiliou S. Yapijakis C, et al. In Vivo. 2023 Jan-Feb;37(1):36-46. doi: 10.21873/invivo.13052. In Vivo. 2023. PMID: 36593018 Free PMC article. Review. - Clinical and Genetic Studies of the First Monozygotic Twins with Pfeiffer Syndrome.
Kantaputra PN, Angkurawaranon S, Khwanngern K, Ngamphiw C, Intachai W, Adisornkanj P, Tongsima S, Olsen B, Sonsuwan N, Katanyuwong K. Kantaputra PN, et al. Genes (Basel). 2022 Oct 13;13(10):1850. doi: 10.3390/genes13101850. Genes (Basel). 2022. PMID: 36292735 Free PMC article. - Computed tomography findings of Crouzon syndrome: A case report.
Neira JGA, Herazo VDC, Cuenca NTR, Sanabria Cano AM, Sarmiento MFB, Castro MF, Ortiz AFH. Neira JGA, et al. Radiol Case Rep. 2022 Feb 17;17(4):1288-1292. doi: 10.1016/j.radcr.2022.01.060. eCollection 2022 Apr. Radiol Case Rep. 2022. PMID: 35242254 Free PMC article. - RUNX2-modifying enzymes: therapeutic targets for bone diseases.
Kim WJ, Shin HL, Kim BS, Kim HJ, Ryoo HM. Kim WJ, et al. Exp Mol Med. 2020 Aug;52(8):1178-1184. doi: 10.1038/s12276-020-0471-4. Epub 2020 Aug 13. Exp Mol Med. 2020. PMID: 32788656 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- 5 R01 DE016887/DE/NIDCR NIH HHS/United States
- 5 R01 DE018500/DE/NIDCR NIH HHS/United States
- 5 R01DE018500-02S1/DE/NIDCR NIH HHS/United States
- 501 DD000350/DD/NCBDD CDC HHS/United States
LinkOut - more resources
Full Text Sources